Effect of Crocus sativus L. (saffron) and crocin in the treatment of patients with type-2 diabetes mellitus: A systematic review and meta-analysis

• Published in: Journal of ethnopharmacology 2024-01, Vol.319, p.117255-117255, Article 117255
• Main Authors: Amatto, Pedro de Padua G., Chaves, Lucas, Braga, Giovana Graça, Carmona, Fábio, Pereira, Ana Maria Soares
• Format: Article
• Language: English
• Subjects: Cardiovascular risk factors; Meta-analysis; Saffron; Systematic review; Type-2 diabetes mellitus
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2023.117255

Crocus sativus L. (saffron, Iridaceae) has been traditionally used for thousands of years as herbal medicine for many diseases, including type-2 diabetes mellitus (T2DM), especially in Sri Lanka. Systematic reviews and meta-analysis on C. sativus for T2DM value traditional knowledge about this species. To assess the effectiveness of C. sativus powdered plant, hydroethanolic extract and crocin in reducing fasting blood sugar (FBG), glycated hemoglobin (HbA1c), blood pressure, and other metabolic parameters in patients with T2DM. Systematic review and meta-analysis based on searches in PubMed, Embase, and Cochrane, including all randomized clinical trials (RCTs) published before January 2, 2023. Two independent reviewers extracted the data and assessed the risks of bias. The effects of C. sativus and crocin were assessed on glycemic, metabolic, and blood pressure parameters. Weighted (WMD) or standardized (SMD) mean differences (before-after) and 95% confidence intervals (95%CI) of the outcomes were extracted or estimated and meta-analyses were conducted using RevMan 5.4 (Cochrane Collaboration). This protocol was registered in PROSPERO (#CRD42023390073). Fifteen of 29 studies were included. Saffron powdered plant decreased AST (WMD -1.19, 95%CI -2.24, −0.13), but increased BMI (WMD 0.56, 95%CI 0.07, 1.05); saffron extract decreased HbA1c (WMD -0.35, 95%CI -0.65, −0.06), FBG (WMD -26.90, 95%CI -38.87, −14.93), creatinine (WMD -0.12, 95%CI -0.19, −0.05), and total cholesterol (WMD -9.29, 95%CI -18.25, −0.33); and crocin decreased HbA1c (WMD -0.43, 95%CI -0.66, −0.20), FBG (WMD -14.10, 95%CI -22.91, −5.30), and systolic blood pressure (WMD -8.18, 95%CI -12.75, −3.61), but increased creatinine levels (WMD 0.24, 95%CI 0.17, 0.32). Of the 15 included studies, 14 had a moderate risk of bias, and one study had a low risk of bias. C. sativus (saffron) powdered plant, extract, and crocin have potential as an adjunct treatment for T2DM, improving control of metabolic and clinical parameters. However, C. sativus extract seems to be superior because it was effective in more parameters and did not induce adverse effects. Since many studies were at moderate risk of bias, further high-quality research is needed to firmly establish the clinical efficacy of this plant. [Display omitted] •Crocus sativus L. (saffron) is traditionally used for type-2 diabetes mellitus (T2DM).•We conducted a systematic review and meta-analysis with 15 studies.•Saffron powdered plant decreased AS